Generic tendency of metal salt cytotoxicity for six cell lines
✍ Scribed by Yamamoto, Akiko ;Honma, Rieko ;Tanaka, Ayako ;Sumita, Masae
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 207 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
✦ Synopsis
Systematic cytotoxicity evaluation of various metallic elements may contribute to the development of new metallic biomaterials with superior biocompatibility. It is generally reported that the cytotoxicity of a chemical differs with cell lines. However, our previous study revealed a high correlation in the cytotoxicity of 43 metal salts between two murine cell lines. If there is any generic tendency toward metal salt cytotoxicity for many kinds of cells, that information is helpful for the determination of the chemical composition of new metallic biomaterials that are expected to have lower cytotoxicity. In this study, the cytotoxicity of 12 metal salts was evaluated using four cell lines, and the results were compared, including those for two other cell lines obtained in our previous study. A metal salt concentration that reduced cell viability to 50% of that without any metal salt (IC 50 ) was used as an index to compare the metal salt cytotoxicity between cell lines. The correlation was statistically proved by the IC 50 s of 12 metal salts among these cell lines (p < 0.01), suggesting the existence of a generic tendency to metal salt cytotoxicity beyond cell lines. The metal salt order of toxicity from the highest was K 2 Cr 2 O 7 , AgNO 3 , VCl 3 , SbCl 3 , CuCl 2 , CoCl 2 , NiCl 2 , ZnCl 2 , Cr(NO 3 ) 3 , FeCl 3 , TiCl 4 , and Al(NO 3 ) 3 . The sensitivity for metal salt cytotoxicity differed with cell lines; IMR-32 had the highest sensitivity among the six cell lines.
📜 SIMILAR VOLUMES
## Abstract Renal cell carcinomas (RCCs) are supposed to be immunogenic, and several clinical trials of immunotherapy using tumor lysate‐pulsed dendritic cells (DCs) have been performed. We report on the generation of RAGE‐1 and MAGE‐9 peptide‐specific CTL lines. RAGE‐1 and MAGE‐9 are expressed in